Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial
出版年份 2021 全文链接
标题
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial
作者
关键词
-
出版物
CIRCULATION
Volume 145, Issue 6, Pages 437-447
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-11-14
DOI
10.1161/circulationaha.121.057983
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Universal Definition and Classification of Heart Failure
- (2021) Biykem Bozkurt et al. JOURNAL OF CARDIAC FAILURE
- Cardiovascular Disease in Chronic Kidney Disease
- (2021) Joachim Jankowski et al. CIRCULATION
- Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study
- (2021) Lisa Chu et al. CLINICAL THERAPEUTICS
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2021) Theresa A McDonagh et al. EUROPEAN HEART JOURNAL
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
- (2021) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes Mellitus and Heart Failure
- (2021) Filippos Triposkiadis et al. Journal of Clinical Medicine
- Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: a large multinational cohort study
- (2020) Kåre I. Birkeland et al. DIABETES OBESITY & METABOLISM
- Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases
- (2020) Bochra Zareini et al. Circulation-Cardiovascular Quality and Outcomes
- Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
- (2020) Rajiv Agarwal et al. EUROPEAN HEART JOURNAL
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)
- (2020) Michael Urbich et al. PHARMACOECONOMICS
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
- (2020) Darren K. McGuire et al. JAMA Cardiology
- Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction
- (2019) Yajie Xiang et al. MEDICINE
- Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
- (2019) Janani Rangaswami et al. CIRCULATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart Failure With Reduced Ejection Fraction and Renal Dysfunction
- (2019) Anita Deswal JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2018) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiorenal Syndrome Revisited
- (2018) Faiez Zannad et al. CIRCULATION
- Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease
- (2017) Lauren B. Cooper et al. Journal of the American Heart Association
- Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney DiseaseCLINICAL PERSPECTIVE
- (2016) Priyesh A. Patel et al. Circulation-Heart Failure
- SGLT2 Inhibitors and the Diabetic Kidney
- (2016) Paola Fioretto et al. DIABETES CARE
- Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation
- (2016) Jozine M. ter Maaten et al. EUROPEAN JOURNAL OF HEART FAILURE
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction
- (2015) Carolyn SP Lam Diabetes & Vascular Disease Research
- The kidney in heart failure: an update
- (2015) Kevin Damman et al. EUROPEAN HEART JOURNAL
- The Global Health and Economic Burden of Hospitalizations for Heart Failure
- (2014) Andrew P. Ambrosy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. CIRCULATION
- Renal dysfunction and heart failure: things are seldom what they seem
- (2013) G. Filippatos et al. EUROPEAN HEART JOURNAL
- Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
- (2013) Bertram Pitt et al. EUROPEAN HEART JOURNAL
- Cellular and molecular mechanisms of renal fibrosis
- (2011) Youhua Liu Nature Reviews Nephrology
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started